ES2170645A1 - Forma farmaceutica solida de administracion oral de una sal de metamizol soluble en agua, procedimiento para su obtencion y forma de presentacion de dicha forma farmaceutica. - Google Patents

Forma farmaceutica solida de administracion oral de una sal de metamizol soluble en agua, procedimiento para su obtencion y forma de presentacion de dicha forma farmaceutica.

Info

Publication number
ES2170645A1
ES2170645A1 ES200000711A ES200000711A ES2170645A1 ES 2170645 A1 ES2170645 A1 ES 2170645A1 ES 200000711 A ES200000711 A ES 200000711A ES 200000711 A ES200000711 A ES 200000711A ES 2170645 A1 ES2170645 A1 ES 2170645A1
Authority
ES
Spain
Prior art keywords
metamisol
giving
solid pharmaceutical
supplied
oral solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200000711A
Other languages
English (en)
Other versions
ES2170645B1 (es
Inventor
Cuevas Gabriel Perez
De Blas Andres Pinilla
Munoz Gabriel Fontes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LABORATORIOS ALCALA FARMA SL
Original Assignee
LABORATORIOS ALCALA FARMA SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LABORATORIOS ALCALA FARMA SL filed Critical LABORATORIOS ALCALA FARMA SL
Priority to ES200000711A priority Critical patent/ES2170645B1/es
Publication of ES2170645A1 publication Critical patent/ES2170645A1/es
Application granted granted Critical
Publication of ES2170645B1 publication Critical patent/ES2170645B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Forma farmacéutica sólida de administración oral de una sal de metamizol soluble en agua, procedimiento para su obtención y forma de presentación de dicha forma farmacéutica. La forma farmacéutica contiene una sal de metamizol farmacéuticamente aceptable, como principio activo, en una matriz sólida granular soluble en agua, que puede ser reconstituida en agua, dando lugar a una suspensión o disolución de sabor agradable. El procedimiento de obtención de dicha forma farmacéutica comprende la mezcla de los componentes, la granulación y la homogeneización de los gránulos obtenidos. La forma farmacéutica es adecuada para la elaboración de una forma de presentación de un medicamento que contiene una sal de metamizol farmacéuticamente aceptable como principio activo, por ejemplo, en forma de sobres monodosis que contienen dicha forma farmacéutica en una dosificación determinada.
ES200000711A 2000-03-23 2000-03-23 Forma farmaceutica solida de administracion oral de una sal de metamizol soluble en agua, procedimiento para su obtencion y forma de presentacion de dicha forma farmaceutica. Expired - Fee Related ES2170645B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES200000711A ES2170645B1 (es) 2000-03-23 2000-03-23 Forma farmaceutica solida de administracion oral de una sal de metamizol soluble en agua, procedimiento para su obtencion y forma de presentacion de dicha forma farmaceutica.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200000711A ES2170645B1 (es) 2000-03-23 2000-03-23 Forma farmaceutica solida de administracion oral de una sal de metamizol soluble en agua, procedimiento para su obtencion y forma de presentacion de dicha forma farmaceutica.

Publications (2)

Publication Number Publication Date
ES2170645A1 true ES2170645A1 (es) 2002-08-01
ES2170645B1 ES2170645B1 (es) 2003-10-01

Family

ID=8492834

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200000711A Expired - Fee Related ES2170645B1 (es) 2000-03-23 2000-03-23 Forma farmaceutica solida de administracion oral de una sal de metamizol soluble en agua, procedimiento para su obtencion y forma de presentacion de dicha forma farmaceutica.

Country Status (1)

Country Link
ES (1) ES2170645B1 (es)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06100602A (ja) * 1992-09-18 1994-04-12 Asahi Chem Ind Co Ltd 経口固形製剤およびその製造方法
WO1996029053A1 (de) * 1995-03-21 1996-09-26 Basf Aktiengesellschaft Transparente, schnell freisetzende zubereitungen von nichtsteroidalen analgetica

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06100602A (ja) * 1992-09-18 1994-04-12 Asahi Chem Ind Co Ltd 経口固形製剤およびその製造方法
WO1996029053A1 (de) * 1995-03-21 1996-09-26 Basf Aktiengesellschaft Transparente, schnell freisetzende zubereitungen von nichtsteroidalen analgetica

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BONDARENKO, O.M. et al. Technology for evaluation of some analgin granules for children. Farm. Zh. (Kiev) (1983), (3), 70-71 (Ucraniano) HCAPLUS en STN, Chemical Abstracts Service (Columbus, Ohio, EEUU) No de acceso 1983:476782 *

Also Published As

Publication number Publication date
ES2170645B1 (es) 2003-10-01

Similar Documents

Publication Publication Date Title
WO2002045684A3 (en) Rapidly dispersing pharmaceutical composition comprising effervescent agents
HUP0204409A2 (en) Sustained release ranolazine pharmaceutical compositions
IL165786A0 (en) Ibuprofen suspension
WO2000013687A3 (en) Sustained release ranolazine formulations
ZA200109859B (en) 6-Alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations.
ATE211907T1 (de) Osmotisches arzneimittelfreisetzungssystem
FR11C0017I1 (es)
HK1061679A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-ibe derivatives, their preparation and their therapeutic use.
GEP20053501B (en) Core Tablet for Controlled Release of Gliclazide after Oral Administration
BG108516A (en) Pharmaceutical formulation
WO2001032181A3 (en) Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum
PL346764A1 (en) New oral formulation for 5-ht4
AU2001264042A1 (en) 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof
IL150528A0 (en) Ibuprofen containing active agent preparation
WO2002049607A3 (en) Flavoured oral drug delivery system
ZA200110517B (en) Metalloprotease inhibitors, a process for their preparation and pharmaceutical compositions containing them.
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
ES2170645A1 (es) Forma farmaceutica solida de administracion oral de una sal de metamizol soluble en agua, procedimiento para su obtencion y forma de presentacion de dicha forma farmaceutica.
HK1045937A1 (en) Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
AU2002218164A1 (en) Animal feed supplement containing d-pantothenic acid and/or its salts, improved method for the production thereof, and its use
WO2002024146A3 (en) Methods of decreasing or preventing pain using spicamycin derivatives
MXPA03006162A (es) Derivados de mikanolida, su preparacion y sus usos terapeuticos.
TW200510335A (en) Water-soluble phenylpyridazine derivatives and medicines containing the same
ATE210428T1 (de) Geschmacksmaskierte wässrige lösungen enthaltend ibuprofen und menthol

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20020801

Kind code of ref document: A1

Effective date: 20020801

FG2A Definitive protection

Ref document number: 2170645B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20180807